GlassScriptPhysician profile
Ethan Pais
NPI 1477118495
$3,386.75
in general payments reported to CMS, 2019-2025
29 companies · $457 in 2025
The $457 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,327 · 2023: $973 · 2024: $630 · 2025: $457.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,060.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,060.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $866.50 | 2022 | |
| Smith+Nephew, INC. | $415.78 | 2023-2025 | Grafix Pl, Stravix, Spatial Frame |
| Acumed LLC | $225.69 | 2023-2024 | Osteomed, Acumed, Inframe Implant |
| Vaporox, INC. | $198.44 | 2023 | Vht-200 Wound Treatment System |
| Medtronic, INC. | $195.64 | 2023-2025 | In.Pact Admiral, Venaseal, Intellis Adaptivestim |
| Integra Lifesciences Corporation | $181.17 | 2022-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Bioventus LLC | $147.70 | 2022-2025 | Exogen Ultrasound Bone Healing System |
| Paratek Pharmaceuticals, INC. | $122.79 | 2022-2025 | Nuzyra |
| Ani Pharmaceuticals, INC. | $103.76 | 2023-2025 | Purified Cortrophin Gel |
| Tactile Systems Technology INC | $99.62 | 2023-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Dynasplint Systems INC. | $83.97 | 2022 | |
| Nevro Corp. | $81.01 | 2022-2023 | Senza |
| Ibsa Pharma INC. | $79.30 | 2023-2025 | Licart, Tirosint, Flector |
| Shockwave Medical, INC | $71.33 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Kerecis Limited | $67.85 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $62.99 | 2022-2025 | Physio-Stim |
| Averitas Pharma INC. | $55.92 | 2023 | Qutenza |
| Treace Medical Concepts, INC. | $53.49 | 2022 | |
| Sebela Pharmaceuticals INC. | $42.47 | 2022-2023 | Naftin |
| Bone Support INC. | $41.25 | 2025 | Cerament G, Ceramentbone Void Filler |
| Amgen INC. | $38.42 | 2024-2025 | Krystexxa |
| Kowa Pharmaceuticals America, INC. | $30.51 | 2022-2023 | Seglentis |
| Mimedx Group, INC. | $22.88 | 2024 | |
| Paragon 28, INC. | $20.69 | 2023 | Additive Orthopedics |
| Kairos Surgical INC | $18.19 | 2024 | |
| Lifenet Health | $16.03 | 2024 | Theragenesis Wound Matrix |
| Reprise Biomedical, INC. | $15.62 | 2024 | Miro3d |
| Ebi, LLC | $13.89 | 2025 | Ebi Osteogen Implantable Bone Growth Stimulator, Biomet Ebi Bone Healing System, Biomet Orthopak Non-Invasive Bone Growth Stimulator System |
| Kci USA, INC. | $13.85 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ethan Pais listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.